pk10走势图怎么看性别

83 pharmaceuticals into a "one-vote" variety pharmaceutical business in need of transformation

Release date: 2020-01-06 Views: 0

According to reporters, letrozole tablets, nilotinib capsules, everolimus tablets, imatinib mesylate tablets, tigio capsules, lenalidomide capsules, paclitaxel for injection (albumin-binding type) 83 drugs, such as azacitidine for injection, pidotimod oral solution, and ceftazidime for injection, were identified as one ticket product.

 

The notice stated that according to the "Two-vote System" Implementation Plan for Public Procurement of Medicines in Gansu Province (Trial), the former Provincial Health and Family Planning Commission and other six departments "Notice on the" Two-vote System "for Procurement of Medicines in Public Medical Institutions in Gansu Province ", The Provincial Medical Security Bureau's" Notice on the declaration of items in the "two-vote system" for the purchase and sale of drugs "requires that, after rigorous review, the company and product information approved in the ninth batch of review be published.


2019年12月30日至2020年1月2日。 The publicity period is: December 30, 2019 to January 2, 2020.

 

4 types of situations can be considered as one vote

 

The reporter inquired the "Notice on Reporting Matters That Are Determined as One Vote in the" Two-vote System "for Drug Purchase and Sale" and found that the notice stipulates that the one-vote system identification work is temporarily continued by the Gansu Provincial Medical Security Bureau.

 

According to the notice, the reporting enterprise must be a production and operation enterprise that participates in the pharmaceutical distribution of Gansu Province's centralized procurement network of pharmaceuticals and medical consumables and the pharmaceutical sunshine procurement platform, and has relevant conditions that can be regarded as a one-vote situation.

 

There are the following categories:

 

A wholly-owned or holding commercial company (only one commercial company in the country) set up by a pharmaceutical manufacturing company or a group-type enterprise integrating science, industry, and trade that sells only its own company (group); domestic general agent for overseas medicines (only one in the country) Domestic distributors); the pharmaceutical marketing license holders apply for the entrusted production and operation enterprises as the production enterprises; group-type distribution enterprises.

 

According to inquiries from reporters, Gansu Province has announced the notice of the first batch of audit results in the "two-vote system" for drug purchase and sale from December 2017. As of the end of 2019, nine batches have been issued.

 

Except for Gansu Province, on August 2, 2019, the Guangdong Provincial Drug Exchange gave a clear answer to the question of invoicing a commercial company that was considered a manufacturing company. Of the first batch of audit results ". The audit results of Guangdong Province show that the production company's business company that sells only its own products is considered as "0 votes" between the parent company and the parent company.

 

One ticket system, bloom everywhere

 

On November 15, the National Health Commission issued the Notice of the State Council Leading Group on Deepening the Reform of the Medical and Health System on Further Promoting the Experience of Deepening the Reform of the Medical and Health System in Fujian Province and Sanming City.

 

The notice requires that the provinces piloting comprehensive medical reform should take the lead in promoting the settlement of payment by the medical insurance agency directly with pharmaceutical production or distribution companies, and other provinces should also actively explore.

 

The data show that as early as 2016, Fujian Province clearly required hospitals to settle directly with drug manufacturers when purchasing basic infusions, and manufacturers should directly issue corresponding drug sales invoices to medical institutions, and medical institutions should count within 30 days from the time of arrival. Settlement of funds is strictly implemented by one-vote system.

 

Some insiders have analyzed and pointed out that according to the documents of the State Council, Jiangsu, Anhui, Fujian, Shanghai, Zhejiang, Hunan, Chongqing, Sichuan, Shaanxi, Qinghai and Ningxia may implement a one-vote system.

 

In addition, according to reporters' incomplete combing, Shandong, Shanxi, Tianjin, Zhejiang and other places have already tried the "one-vote system" for medicines. In the local version of the tape purchase plan in Hubei and Anhui, there is a clear statement that encourages the one-vote system.

 

Pharmaceutical business urgently needs transformation

 

The so-called "one-vote system" means that the manufacturer's medicines directly reach the medical insurance designated medical institutions (hospitals and pharmacies) to issue an invoice. There is no intermediate agent home. The manufacturer's payment is directly settled with the medical insurance fund, which is the so-called "one-vote system".

 

In the process of promoting the two-vote system and encouraging the one-vote system, the most affected pharmaceutical business groups-agents and pharmaceutical natural persons.

 

Some analysts have pointed out that under a one-vote system, pharmaceutical manufacturers settle directly with hospitals. On this basis, commerce no longer plays the role of fund advancement in drug circulation, but retires to provide specialized pharmaceutical logistics distribution functions.

 

However, some people in the industry believe that the trouble for pharmaceutical commercial companies is that they may not be able to compete with social logistics such as SF in terms of distribution costs and quality on the basis of losing their original advantages.

 

Some suggestions point out that if a one-vote system is implemented in the future, commercial companies can only choose to transform—putting into the embrace of production companies or transforming to serve hospitals and other institutions, detach from existing operating models, and transform into consulting institutions.


common name Product name Packaging Remark
Alogliptin benzoate tablets Nisina 25mg * 10 tablets / box
Letrozole tablets Furlong 2.5mg * 10 tablets / box
Letrozole tablets Furlong 2.5mg * 30 tablets / box
Nilotinib capsules Dasina 0.2g * 120 capsules / box
Nilotinib capsules Dasina 150mg * 120 capsules / box
Everolimus tablets Peneto 2.5mg * 30 tablets / box
Everolimus tablets Peneto 5mg * 30 tablets / box
Lucotinib phosphate tablets Geckowei 5mg * 60 tablets / box
Zoledronic acid solution for injection
5ml: 4mg * 1
Perazopanib Vicente 100mg
Octreotide acetate microspheres for injection Shanlong 20mg * 1
Octreotide acetate microspheres for injection Shanlong 30mg * 1 bottle / box
Deferoxamine mesylate for injection Desfin 0.5g * 1 bottle / box
Imatinib mesylate SF 0.1g * 60 tablets / box
Ceritinib capsules Zanda 150mg * 150 capsules / box
Delarox dispersible tablets Enrig 125mg * 28 tablets / box
Eltropopa ethanolamine tablets Rivran 25mg * 28 tablets / box
Tigio Capsules Aswan 20mg * 28 capsules / box
Tigio Capsules Aswan 25mg * 28 capsules / box
Lenalidomide capsules Refumei 25mg * 21 capsules / box
Lenalidomide capsules Refumei 10mg * 21 capsules / box
Paclitaxel for injection (albumin-bound type)
100mg * 1 bottle / box
Azacitidine for injection Vedasa 100mg * 1 bottle / box
Melphalan hydrochloride for injection
50mg * 1 bottle / box
Diclofenac sodium double-release enteric-coated capsules Defen 75mg * 10 capsules / box
Diclofenac sodium double-release enteric-coated capsules Defen 75mg * 20 capsules / box
Pidotimod oral solution Primo 400mg: 7ml * 10 bottles / box
Nifuratel Nystatin Vaginal Soft Capsule Mimi Compa 500mg: 200,000 IU * 6 capsules / box
Low molecular weight heparin sodium injection Schiffen 0.3ml: 3200IUaXa
Low molecular weight heparin sodium injection Schiffen 0.4ml: 4250IUaXa
Low molecular weight heparin sodium injection Schiffen 0.6ml: 6400IUaXa
Creatine phosphate for injection Learton 1g * 1 bottle / box
Cefotiam hydrochloride for injection Fu Xianan 0.5g
Cefotiam hydrochloride for injection Fu Xianan 1.0g
Ceftazidime for injection Tedesin 0.5g
Ceftazidime for injection Tedesin 1.0g
Iodobiol injection Three generations 50ml: 17.5g (I)
Iodobiol injection Three generations 100ml: 30g (I)
Iodobiol injection Three generations 100ml: 35g (I)
Gadoterate glucosamine injection Dotalin 15ml (377mg / ml)
High-purity urotropin for injection He Meiqi 75IU FSH + 75IU LH
Imipenem / cilastatin sodium for injection Spectral energy 1g (1: 1)
Cefodizime Sodium for Injection Dickin 0.5g
Cefodizime Sodium for Injection Dickin 1.0g
Glucosamine Sulfate Capsules Gu Li 0.25g * 24 capsules
Glucosamine Sulfate Capsules Gu Li 0.25g * 42 capsules
Glucosamine Sulfate Capsules Gu Li 0.25g * 100 capsules
Recombinant follicle stimulating hormone b injection Priecon 50IU / 0.5ml / piece
Recombinant follicle stimulating hormone b injection Priecon 100IU / 0.5ml / piece
Recombinant follicle stimulating hormone b injection Priecon 300IU / 0.36ml / piece (refill syringe system)
Recombinant follicle stimulating hormone b injection Priecon 600IU / 0.72ml / piece (refill syringe system)
Ganiric Acetate Injection Ogali 0.5ml: 0.25mg (calculated by Ganeric)
Leo Si Angio 0.5mgx42 tablets
Leo Si Angio 1mgx42 tablets
Leo Si Angio 2.5mgx84 tablets
Mometasone Furoate Nasal Spray Nesuna 50μg / 揿 (0.05%, 60 揿)
Mometasone Furoate Nasal Spray Nesuna 50μg / 揿 (0.05%, 140 揿)
Elbaway Grave Chopita Each tablet contains Elbavir 50mg and Glarevir 100mg * 28
Temozolomide capsules Tadao 20mg
Temozolomide capsules Tadao 100mg
Tigio Capsules Aswan 20mg * 28 capsules / box The original second batch was announced and is now withdrawn.
Tigio Capsules Aswan 25mg * 28 capsules / box The original second batch was announced and is now withdrawn.
Lenalidomide capsules Refumei 25mg * 21 capsules / box The original second batch was announced and is now withdrawn.
Lenalidomide capsules Refumei 10mg * 21 capsules / box The original second batch was announced and is now withdrawn.
Paclitaxel for injection (albumin-bound type)
100mg * 1 bottle / box The original second batch was announced and is now withdrawn.
Azacitidine for injection Vedasa 100mg * 1 bottle / box The original seventh batch was announced and is now withdrawn.
Diclofenac sodium double-release enteric-coated capsules Defen 75mg * 10 capsules / box The original second batch was announced and is now withdrawn.
Diclofenac sodium double-release enteric-coated capsules Defen 75mg * 20 capsules / box The original second batch was announced and is now withdrawn.
Pidotimod oral solution Primo 400mg: 7ml * 10 bottles / box The original second batch was announced and is now withdrawn.
Nifuratel Nystatin Vaginal Soft Capsule Mimi Compa 500mg: 200,000 IU * 6 capsules / box The original second batch was announced and is now withdrawn.
Low molecular weight heparin sodium injection Schiffen 0.3ml: 3200IUaXa The original second batch was announced and is now withdrawn.
Low molecular weight heparin sodium injection Schiffen 0.4ml: 4250IUaXa The original second batch was announced and is now withdrawn.
Low molecular weight heparin sodium injection Schiffen 0.6ml: 6400IUaXa The original second batch was announced and is now withdrawn.
Creatine phosphate for injection Learton 1g * 1 bottle / box The original second batch was announced and is now withdrawn.
Iodobiol injection Three generations 50ml: 17.5g (I) / bottle The original first batch of announcements are now withdrawn.
Iodobiol injection Three generations 100ml: 30g (I) / bottle The original first batch of announcements are now withdrawn.
Iodobiol injection Three generations 100ml: 35g (I) / bottle The original first batch of announcements are now withdrawn.
Gadoterate glucosamine injection Dotalin 15ml (377mg / ml) / bottle The original first batch of announcements are now withdrawn.
High-purity urotropin for injection He Meiqi 75IU FSH + 75IU LH The original sixth batch was announced and is now withdrawn.
Imipenem / cilastatin sodium for injection Spectral energy 1g (1: 1) The original third batch was announced and is now withdrawn.
Glucosamine Sulfate Capsules Gu Li 0.25g * 24 capsules The original third batch was announced and is now withdrawn.
Glucosamine Sulfate Capsules Gu Li 0.25g * 42 capsules The original third batch was announced and is now withdrawn.
Glucosamine Sulfate Capsules Gu Li 0.25g * 100 capsules The original third batch was announced and is now withdrawn.

recommended article

Hunter QR code